October 25, 2019 at 06:17PM Flebogamma DIF 5% & 10%

Product approval information is indicated for:
•Flebogamma 5% DIF: Treatment of primary (inherited) immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.
•Flebogamma 10% DIF: Treatment of (1) primary (inherited) immunodeficiency; (2) chronic primary immune thrombocytopenia (ITP) in patients 2 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JmG3ki